Skip to content

The Clinical Effect of actual patient with navel acupuncture and The Tianjing Huayu Prescription in preventing recurrence of intrauterine adhesion after transcervical resection of adhesion

The Clinical Effect of actual patient with navel acupuncture and The Tianjing Huayu Prescription in preventing recurrence of intrauterine adhesion after transcervical resection of adhesion

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000258
Enrollment
Unknown
Registered
2024-08-19
Start date
2023-08-01
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrauterine adhesion

Interventions

group1:Complex Packing Estradiol Tablets(Pharmaceutical company name: Abbott Healthcare products B.V., approval number: H20150345)
group3: Navel acupuncture and Tianjing Huayu Prescription Combined with Complex Packing Estradiol Tablets(Pharmaceutical company name: Abbott Healthcare products B.V., approval number: H20150345)
group2:Tianjing Huayu Prescription Combined with Complex Packing Estradiol Tablets(Pharmaceutical company name: Abbott Healthcare products B.V., approval number: H20150345)

Sponsors

The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
24 Years to 40 Years

Inclusion criteria

Inclusion criteria: Only those who meet all the following criteria can be selected: (1) Meets the diagnostic criteria of traditional Chinese and Western medicine for intrauterine adhesions (kidney deficiency and blood stasis syndrome); (2) Between the ages of 24 and 40; (3) Individuals with fertility needs; (4) Agree to the treatment content, voluntarily participate in the project research, and sign the consent.

Exclusion criteria

Exclusion criteria: Those who meet any of the following criteria need to be excluded: (1) early ovarian insufficiency, PCOS, peri-menopausal period and other abnormal gonadal axis lead to hypomenorrhea or even amenorrhea. (2) patients with breast cancer, estrogen-sensitive tumors or other malignant tumors. (3) patients with unexplained vaginal bleeding. (4) patients with severe mental disorders such as liver, kidney, heart, brain, vascular disease or cognitive impairment. (5) patients with thrombosis or active thromboembolism. (6) porphyria. (7) patients with abdominal edema, navel inflammation, ulcer and eczema. (8) those who have been treated with steroid drugs in the past three months. (9) pregnant or lactating patients. (10) A person who is allergic to the active ingredient of a therapeutic drug or any excipient.

Design outcomes

Primary

MeasureTime frame
American Fertility Society score;

Secondary

MeasureTime frame
Endometrial thickness;TCM syndrome score;clinical pregnancy rate;

Countries

China

Contacts

Public ContactJing Sun

The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine

Sunjng790825@126.com+86 182 4023 5350

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026